Review of current chemoinformatic tools for modeling important aspects of CYPs-mediated drug metabolism. Integrating metabolism data with other biological profiles to enhance drug discovery.
The study of the metabolism of xenobiotics by the human body is an essential stage in the complex and expensive process of drug discovery, being one of the main causes of disapproval and/or withdrawal of drugs. Regarding this, enzymes known as cytochromes P450 (CYPs) play a very decisive role in the biotransformation of many chemicals. For this reason, the use of chemoinformatics to predict and /or analyze from different points of view CYPs-mediated drug metabolism, can help to reduce time and financial resources. This work is focused on the most remarkable advances in the last 5 years of the chemoinformatics tools towards the virtual analysis of CYPsmediated drug metabolism. First, a brief section is dedicated to the applicability of chemoinformatics in different areas associated with drug metabolism. Then, both the models for prediction of CYPs substrates and those allowing the assessment of sites of metabolism (SOM) are discussed. At the same time, the principal limitations of the current chemoinformatic tools are pointed out. Finally, and taking into account that metabolism is an essential step in the whole process of designing any drug, we introduce here as a case of study, the first multitasking model for quantitative-structure biological effect relationships (mtk-QSBER). The purpose of this model is to integrate different types of biological profiles such as ADMET (absorption, distribution, metabolism, excretion, toxicity) profiles and antistaphylococci activities. The mtk-QSBER model was created by employing a heterogeneous dataset of more than 66000 cases tested in 6510 different experimental conditions. The model displayed a total accuracy higher than 94%. To the best of our knowledge, this is the first attempt to complement metabolism assays with other relevant biological data in order to speed up the discovery of efficacious antistaphylococci agents.